franc
recent
wit
nationwid
outbreak
easl
viru
mv
small
spheric
envelop
singlestrand
rna
viru
belong
genu
morbilliviru
famili
paramyxovirida
despit
avail
effect
vaccin
year
measl
still
repres
major
harbing
death
low
incom
countri
affect
chiefli
malnourish
infant
claim
live
per
year
although
supposedli
verg
extinct
franc
mv
reemerg
spectacularli
sinc
regist
case
measl
last
year
outbreak
repeatedli
report
elsewher
europ
call
question
assumpt
measl
diseas
confin
develop
countri
recent
work
point
insuffici
vaccin
coverag
main
reason
resurg
measl
strengthen
claim
diseas
like
pose
uniqu
challeng
come
year
anoth
major
sourc
concern
grow
proport
young
adult
affect
epidem
age
group
prone
sever
complic
enceph
pneumonia
comparison
profus
data
avail
recent
measl
epidem
knowledg
studi
address
specif
sever
measl
affect
adult
popul
yet
conduct
herein
report
case
patient
measl
requir
icu
admiss
retrospect
studi
case
detect
conduct
nationwid
survey
franc
elig
studi
inclus
confirm
measl
infect
diagnos
contact
icu
declin
particip
nineteen
icu
provid
total
case
measl
deem
confirm
presenc
follow
symptom
record
whenev
possibl
gener
rash
last
day
temperatur
cough
coryza
conjunct
addit
posit
serolog
test
detect
measl
virusspecif
nucleic
acid
revers
transcript
polymeras
chain
reaction
rtpcr
serolog
test
deem
posit
presenc
immunoglobulin
antibodi
igm
case
signific
rise
measl
antibodi
level
standard
serolog
assay
event
posit
laboratori
test
patient
aforement
clinic
featur
accord
guidelin
unit
state
center
diseas
control
prevent
cdc
case
indigen
acquir
accord
measl
classif
establish
cdc
mean
either
case
could
link
local
transmiss
rash
occur
day
enter
french
territori
studi
approv
ethic
committe
de
de
langu
patient
includ
collect
data
describ
use
standard
data
collect
form
help
patient
attend
physician
icu
data
includ
demograph
featur
measl
vaccin
statu
presenc
type
immunodefici
underli
cardiovascular
respiratori
comorbid
possibl
crosstransmiss
persontoperson
contact
simplifi
acut
physiolog
score
sap
ii
obes
defin
bodi
mass
index
kgm
complianc
recommend
set
world
health
organ
crosstransmiss
defin
histori
contact
probabl
confirm
case
measl
within
day
rash
onset
full
immun
consid
vaccin
regimen
administ
infanc
agreement
guidelin
admiss
symptom
relat
measl
infect
defin
cdc
includ
presenc
sign
sought
fever
defin
bodi
temperatur
admiss
icu
antimicrobi
treatment
steroid
nonsteroid
antiinflammatori
drug
nsaid
administ
cours
diseas
record
patient
respiratori
compromis
subsequ
measl
infect
note
time
onset
measl
infect
defin
presenc
morbil
rash
occurr
dyspnea
review
time
cours
everi
clinic
event
relat
measl
includ
characterist
featur
less
common
complic
admiss
icu
follow
laboratori
paramet
collect
avail
creatinin
kinas
ck
level
serum
creatinin
serum
liver
enzym
marker
level
includ
aminotransferas
alkalin
phosphatas
bilirubin
platelet
count
total
lymphocyt
count
blood
gase
lymphopenia
defin
total
lymphocyt
count
diagnost
criteria
measlesassoci
rhabdomyolysi
includ
ck
plasma
level
rise
time
upper
limit
normal
laboratori
rang
exclus
potenti
caus
rhabdomyolysi
diagnosi
measlesrel
hepat
base
increas
serum
aminotransferas
least
time
upper
limit
normal
laboratori
rang
absenc
preexist
liver
diseas
rhabdomyolysi
potenti
caus
elev
serum
aminotransferas
thrombocytopenia
character
platelet
count
cellsmm
whenev
possibl
thorac
imag
perform
within
hour
icu
admiss
review
attend
physician
radiologist
case
chest
xray
thorac
comput
tomographi
chest
ct
scan
higher
prioriti
given
chest
ct
term
definit
interpret
detail
regard
support
care
oxygen
case
acut
respiratori
failur
collect
upon
admiss
monitor
throughout
icu
stay
acut
respiratori
distress
syndrom
ard
defin
complianc
berlin
confer
ard
adjunct
therapi
ard
includ
prone
posit
inhal
nitric
oxid
extracorpor
circul
membran
oxygen
ecmo
record
given
episod
suspect
airway
bacteri
superinfect
follow
data
collect
time
occurr
icu
admiss
site
infect
tracheobronch
sinus
otiti
pneumonia
pneumonia
type
communityacquir
pneumonia
ecap
ventilatorassoci
pneumonia
evap
bacteri
diagnosi
microbiolog
sampl
procedur
antibiot
resist
profil
prescrib
antibiot
durat
treatment
sampl
deem
valid
microbiolog
assess
includ
sputum
cultur
blood
cultur
detect
urin
antigen
streptococcu
pneumonia
legionella
pneumophila
vap
refer
ventilatorassoci
infect
lower
airway
tract
aris
hour
intub
mechan
ventil
set
vap
bacteri
superinfect
defin
presenc
new
infiltr
least
follow
criteria
temperatur
purul
tracheal
secret
purul
sputum
elev
leukocyt
count
posit
quantit
cultur
distal
secret
obtain
tracheal
aspir
threshold
colonyform
unit
ecfuml
bronchoalveolar
lavag
threshold
cfuml
protect
specimen
cathet
threshold
cfuml
accord
prior
data
guidelin
cap
defin
case
microbiolog
document
coinfect
lower
airway
tract
hospit
within
hour
hospit
admiss
patient
requir
mechan
ventil
upon
admiss
microbiolog
sampl
interpret
conduct
fashion
similar
vap
otherwis
spontan
breath
maintain
bacteri
superinfect
base
yield
sputum
cultur
threshold
cfuml
pneumonia
l
pneumophila
urinari
antigen
test
collect
data
relat
antivir
therapi
direct
measl
categori
compris
therapi
aim
directli
measl
ribavirin
polyval
immunoglobulin
ivig
therapi
direct
measlesinduc
inflamm
crossimmun
steroid
plasma
exchang
vitamin
variabl
interest
time
measl
onset
initi
first
measlesdirect
treatment
durat
dose
treatment
patient
surviv
ard
neurolog
complic
follow
measl
infect
detail
regard
clinic
examin
followup
collect
readili
avail
data
report
median
interquartil
rang
iqr
proport
appropri
statist
analysi
perform
use
graphpad
prism
graphpad
softwar
v
yearli
monthli
distribut
case
measl
infect
display
figur
one
patient
whose
final
diagnosi
measl
inclus
bodi
enceph
mibe
includ
analysi
given
undetermin
time
infect
highli
variabl
delay
onset
diseas
inaugur
neurolog
symptom
case
measl
infect
occur
winter
spring
vast
major
case
occur
year
three
epidem
wave
gradual
increas
magnitud
throughout
survey
could
observ
epidem
peak
culmin
februari
baselin
characterist
demograph
icurel
variabl
gener
symptom
patient
measlesassoci
pneumonitisvth
prevail
clinic
patternvar
depict
tabl
total
patient
cohort
consist
men
women
median
age
year
iqr
yr
median
sap
ii
score
admiss
iqr
patient
vaccin
statu
respect
measl
readili
avail
case
patient
receiv
singl
dose
vaccin
patient
never
vaccin
one
patient
report
previous
contract
measl
childhood
potenti
except
patient
none
patient
fulli
immun
measl
measl
infect
develop
result
possibl
crosstransmiss
case
underli
comorbid
condit
chronic
respiratori
diseas
patient
immunosuppress
patient
obes
case
measl
affect
pregnant
women
instanc
patient
contract
measl
week
pregnanc
caus
chronic
respiratori
diseas
group
patient
includ
intermitt
asthma
n
bronchiectasi
n
chronic
obstruct
pulmonari
diseas
n
restrict
lung
diseas
n
reason
immunosuppress
human
immunodefici
viru
hiv
infect
lymphocyt
count
cellmm
month
prior
hospit
admiss
n
mainten
immunosuppress
regimen
kidney
transplant
n
common
variabl
immunodefici
n
stage
iv
nonhodgkin
lymphoma
n
twentyf
patient
deem
healthi
measl
infect
three
patient
receiv
corticosteroid
patient
receiv
nsaid
patient
receiv
none
patient
caus
immunosuppress
case
treatment
either
administ
part
overthecount
selfmed
prescrib
gener
practition
hospit
admiss
follow
characterist
sign
ill
found
upon
hospit
admiss
fever
n
cough
n
coryza
n
pharyng
n
conjunct
n
presenc
sign
note
case
presenc
rash
suggest
measl
either
present
cours
hospit
stay
n
experienc
patient
hospit
sinc
reced
n
case
evid
morbil
rash
hospit
patient
immunodepress
kidney
transplant
n
hiv
n
measl
pneumon
without
bacteri
superinfect
sole
complic
requir
hospit
icu
unit
n
median
time
onset
abbrevi
alat
alanin
aminotransferas
ldh
lactat
dehydrogenas
lo
icu
length
stay
intens
care
unit
defin
bodi
mass
index
kgm
icu
admiss
includ
steroid
nonsteroid
antiinflammatori
therapi
usual
medic
onset
defin
onset
rash
initi
respiratori
symptom
absenc
rash
time
patient
full
immun
defin
complet
regimen
median
level
kmoll
level
iul
count
total
platelet
count
express
cell
per
mm
count
express
cell
per
mm
bronchopulmonari
coinfect
superinfect
entir
hospit
stay
least
area
consolid
thorac
imag
perform
within
hour
icu
admiss
stay
icu
day
measl
develop
dyspnea
day
iqr
one
patient
develop
histolog
ascertain
hecht
giant
cell
pneumonia
follow
measl
infect
first
cours
chemotherapi
nonhodgkin
lymphoma
neurolog
complic
prompt
icu
admiss
observ
case
includ
case
postinfecti
enceph
andor
myeliti
pie
case
mibe
two
patient
develop
respiratori
neurolog
complic
affect
pie
eleven
patient
requir
mechan
ventil
indic
mechan
ventil
acut
respiratori
failur
due
measl
pneumonitisrel
complic
n
measlesinduc
neurolog
complic
n
patient
except
underw
thorac
imag
within
hour
icu
admiss
chest
ct
scan
result
readili
avail
patient
typic
aspect
measl
pneumon
display
figur
thorac
imag
among
patient
admit
measl
disclos
exclus
pattern
interstiti
pneumon
case
patient
chest
ct
scan
perform
disclos
evid
interstiti
lesion
patient
pattern
interstiti
pneumon
consist
micronodular
opac
n
groundglass
opac
n
reticulonodular
lesion
n
mix
alveolar
interstiti
lesion
seen
case
lesion
present
predominantli
bilater
group
patient
thorac
imag
upon
admiss
display
abnorm
case
case
imag
chest
xray
exam
case
bilater
interstiti
lesion
pattern
substanti
followup
exam
remain
patient
prevail
diagnosi
measl
pneumon
biolog
ascertain
measl
infect
signific
hypoxemia
lack
altern
diagnosi
group
patient
cap
along
measl
pneumon
n
area
consolid
notic
instanc
two
patient
use
mechan
ventil
repeat
ct
scan
stay
icu
persist
sever
hypoxemia
case
addit
interstiti
lesion
pattern
initi
substanti
ct
scan
demonstr
lobar
consolid
lower
lobe
evid
fibrosi
thicken
septa
retractil
bronchiectasi
case
bronchiectasi
dissemin
cystic
lesion
neither
patient
microbiolog
evid
pulmonari
superinfect
time
control
chest
ct
scan
perform
clinic
characterist
microbiolog
featur
outcom
among
patient
measl
pneumon
proven
bacteri
superinfect
display
tabl
patient
admit
respiratori
symptom
patient
receiv
antibiot
therapi
icu
admiss
patient
receiv
antibiot
time
medic
manag
ten
episod
pulmonari
bacteri
superinfect
document
patient
includ
case
cap
case
vap
two
patient
immunocompromis
none
pregnant
follow
bacteria
recov
haemophilu
influenza
n
methicillinsensit
staphylococcu
aureu
mssa
n
pseudomona
aeruginosa
n
enterobact
cloaca
n
pneumonia
n
neisseria
meningitidi
n
note
patient
develop
pulmonari
aspergillosi
follow
chemotherapi
stage
iv
nonhodgkin
lymphoma
nineteen
patient
symptom
consist
pharyng
due
measl
one
patient
bacteri
pharyng
consecut
betahemolyt
streptococcu
sinus
occur
instanc
proven
neisseria
meningitidi
superinfect
case
mssa
respons
measlesrel
tracheobronch
superinfect
patient
one
case
otiti
media
report
patient
requir
support
mechan
ventil
went
develop
ard
accord
berlin
definit
patient
met
criteria
sever
ard
patient
could
classifi
moder
ard
addit
patient
mild
ard
none
pregnant
women
requir
mechan
ventil
among
patient
ard
extraalveolar
air
leak
complic
occur
case
patient
die
sever
immunocompromis
case
air
leak
complic
among
patient
measl
pneumon
requir
mechan
ventil
four
patient
progress
refractori
hypoxemia
respond
combin
therapeut
includ
prone
posit
n
n
ecmo
n
extraalveolar
air
leak
complic
affect
patient
repres
incid
group
patient
affect
measl
pneumon
patient
nonsmok
none
experienc
pneumothorax
measl
infect
two
patient
histori
respiratori
diseas
patient
known
bronchiectasi
intermitt
asthma
evid
case
iatrogen
andor
traumat
pneumothorax
patient
use
mechan
ventil
ard
diagnosi
extraalveolar
air
leak
diseas
develop
follow
icu
admiss
thu
motiv
intens
care
manag
condit
manifest
unilater
pneumothorax
case
pneumomediastinum
case
combin
pneumothorax
pneumomediastinum
case
group
patient
die
cours
icu
manag
albeit
none
direct
consequ
air
leak
diseas
detail
clinic
laboratori
investig
present
tabl
neurolog
complic
follow
measl
infect
consist
case
pie
case
probabl
mibe
case
intracerebr
hemorrhag
latter
detail
tabl
direct
connect
could
establish
measl
infect
occurr
intracerebr
hemorrhag
report
case
subacut
scleros
panenceph
none
patient
neurolog
complic
receiv
full
cours
immun
measl
exampl
magnet
reson
imag
mri
morpholog
find
shown
figur
patient
develop
neurolog
symptom
set
pie
within
week
onset
measl
evid
underli
immunosuppress
patient
icu
admiss
patient
typic
morbil
rash
along
fever
case
alter
mental
statu
without
evid
epilepsi
predomin
symptom
third
case
initi
clinic
assess
suggest
mening
patient
experienc
seizur
confirm
electroencephalogram
eeg
cerebr
spinal
fluid
csf
analysi
mild
lymphocyt
pleocytosi
hyperproteinorachia
observ
everi
case
imag
consist
brain
ct
scan
brain
mri
perform
respect
day
day
follow
onset
neurolog
manifest
deem
normal
case
brain
medulla
mri
coron
fluidattenu
invers
recoveri
flair
sequenc
depict
diffus
hyperintens
signal
medulla
indic
myeliti
chest
imag
unveil
evid
pneumon
admiss
mechan
ventil
warrant
case
result
neurolog
failur
concurr
measl
pneumon
affect
patient
kidney
transplant
recipi
present
episod
focal
seizur
affect
right
upper
limb
follow
grand
mal
seizur
one
month
admiss
patient
resum
hemodialysi
follow
kidney
graft
failur
result
transplant
glomerulopathi
without
concurr
reinforc
immunosuppress
regimen
admiss
patient
stupor
hemodynam
respiratori
condit
normal
histori
possibl
measl
crosstransmiss
note
month
first
neurolog
symptom
patient
deni
rash
period
notabl
neurolog
examin
find
includ
motor
aphasia
paralysi
left
lower
limb
clonic
seizur
right
upper
limb
brain
mri
substanti
hyperintens
signal
affect
right
thalamu
peduncl
along
similar
lesion
affect
corticosubcort
region
right
tempor
lobe
right
occipit
lobe
left
frontal
lobe
flair
sequenc
csf
analysi
unremark
patient
immunosuppress
regimen
mycophenol
mofetil
mg
twice
daili
prednison
mg
daili
withheld
gradual
declin
patient
conscious
without
evid
epilepsi
iter
eeg
place
mechan
ventil
week
admiss
sequenti
serolog
test
measl
demonstr
unequivoc
seroconvers
posit
igm
immunoglobulin
g
igg
antibodi
plasma
sampl
contemporan
neurolog
symptom
wherea
third
sampl
abbrevi
g
glucos
content
ly
lymphocyt
count
nl
normal
np
perform
nr
relev
p
protein
content
gl
pmn
polymorphonuclear
leukocyt
count
rbc
red
blood
cell
count
wbc
white
blood
cell
count
time
elaps
onset
measl
defin
occurr
rash
first
neurolog
symptom
day
elaps
onset
measl
defin
occurr
rash
acquisit
mri
day
measl
pneumon
brain
ct
scan
perform
day
onset
neurolog
symptom
deem
normal
collect
month
neurolog
symptom
neg
brain
biopsi
procedur
initi
consid
carri
satisfactori
cours
patient
neurolog
condit
follow
treatment
discontinu
accordingli
control
brain
mri
perform
day
reveal
partial
resolut
aforement
abnorm
preval
laboratori
complic
lymphopenia
affect
patient
lymphocyt
count
readili
avail
admiss
potenti
confound
factor
involv
hiv
infect
n
immunosuppress
regimen
n
chronic
malnutrit
n
median
lymphocyt
level
mm
iqr
mm
complic
includ
diarrhea
n
rhabdomyolysi
n
hepat
n
thrombocytopenia
n
aminotransferas
plasma
level
augment
patient
case
patient
develop
acut
renal
failur
consecut
sever
rhabdomyolysi
absenc
seizur
ck
pick
level
iul
patient
manag
support
care
requir
renal
replac
therapi
whole
aforement
complic
mild
sinc
patient
develop
acut
liver
failur
median
alanin
aminotransferas
level
iul
iqr
iul
bleed
complic
median
platelet
level
iqr
rhabdomyolysi
asymptomat
case
median
ck
level
iul
iqr
iul
variabl
relat
measlesdirect
treatment
depict
tabl
total
patient
receiv
least
follow
treatment
ribavirin
n
ivig
therapi
n
plasma
therapi
n
steroid
n
vitamin
treatment
n
primari
indic
measl
pneumon
complic
ard
n
sever
hypoxemia
n
among
patient
patient
start
antivir
treatment
result
pie
anoth
patient
result
mibe
median
time
diseas
onset
treatment
initi
day
iqr
patient
respiratori
failur
patient
ventilatori
condit
worsen
everi
case
despit
differ
combin
therapi
includ
intraven
ribavirin
case
see
tabl
ultim
patient
surviv
other
die
due
refractori
hypoxemia
multiorgan
failur
one
patient
pie
treat
combin
plasma
exchang
steroid
puls
therapi
slight
motor
improv
observ
follow
treatment
complet
anoth
patient
seizur
relat
pie
underw
cours
ivig
therapi
symptom
free
discharg
hospit
final
patient
mibe
receiv
ribavirin
treatment
prematur
interrupt
day
reassess
indic
advers
event
relat
antivir
treatment
report
except
episod
intravascular
hemolysi
ascrib
ribavirin
day
treatment
advers
effect
deem
sever
enough
warrant
definit
withdraw
treatment
discontinu
ribavirin
hemolysi
fulli
reced
four
patient
die
icu
manag
consequ
refractori
ard
followup
patient
sever
chronic
respiratori
failur
relat
fibros
sequela
month
follow
measl
pneumon
complic
ard
two
patient
mild
gait
disord
due
mild
lower
limb
paraparesi
along
bladder
dysfunct
month
develop
enceph
myeliti
ascrib
measl
follow
discontinu
immunosuppress
treatment
patient
mibe
steadili
improv
next
day
perfect
recoveri
mental
statu
motor
deficit
infrequ
myoclon
jerk
note
month
followup
among
pregnant
patient
cours
pregnanc
unev
case
deliveri
live
infant
expect
term
one
patient
underw
cesarean
deliveri
prompt
fetal
growth
restrict
week
gestat
anoth
develop
preeclampsia
week
gestat
mandat
urgent
vagin
deliveri
neonat
complic
found
mother
offspr
well
followup
current
retrospect
studi
report
case
sever
measl
infect
confirm
laboratori
test
requir
icu
manag
knowledg
largest
seri
sever
measl
infect
highresourc
health
care
set
case
affect
young
adult
median
age
yr
iqr
yr
occur
first
month
n
mirror
yearli
season
nation
epidem
predomin
clinic
pictur
measlesrel
interstiti
pneumon
n
wherea
neurolog
symptom
occur
case
two
differ
scenario
could
delin
group
patient
overal
benign
evolut
note
case
n
howev
small
subset
immunocompromis
patient
observ
sever
cours
frequent
bacteri
superinfect
possibl
propens
barotrauma
high
mortal
rate
diagnost
caveat
includ
subacut
gradual
progress
respiratori
symptom
miss
atyp
morbil
rash
clinic
express
measlesinduc
neurolog
complic
vari
often
mislead
patient
left
sever
neurolog
impair
radiograph
pattern
interstiti
lesion
recogn
characterist
measl
pneumon
find
agreement
previou
report
sinc
patient
measl
pneumon
present
radiograph
abnorm
consist
interstiti
lesion
note
data
regard
radiograph
assess
measl
pneumon
predominantli
base
chest
xray
examin
come
either
set
ct
scan
readili
avail
studi
date
prect
scan
era
patient
ct
scan
admiss
abnorm
display
bilater
micronodular
lesion
groundglass
opac
whether
pattern
specif
sever
measl
pneumon
simpli
ascrib
sampl
bia
requir
investig
anoth
debat
issu
reliabl
chest
imag
correctli
identifi
patient
bacteri
superinfect
result
inconclus
primarili
small
number
patient
cap
n
shown
tabl
seem
unambigu
pattern
suggest
superinfect
patient
normal
time
elaps
onset
measl
defin
onset
morbil
rash
initi
therapi
day
plasma
exchang
withheld
due
measl
specif
treatmentrel
advers
effect
prematur
stop
due
fear
advers
effect
insuffici
evid
efficaci
chest
xray
exam
patient
bilater
interstiti
opac
rightsid
alveolar
opac
bilater
mix
alveolar
interstiti
opac
howev
studi
address
question
demonstr
presenc
lobar
consolid
dens
infiltr
neither
sensit
specif
bacteri
coinfect
possibl
explan
regard
poor
discriminatori
perform
chest
imag
may
resid
possibl
natur
histori
measlesassoci
interstiti
pneumon
dynam
pattern
lesion
highlight
result
repeat
scan
patient
measlesassoci
ard
suggest
lobar
consolid
might
result
progress
coalesc
micronodular
lesion
whether
bacteri
superinfect
occur
current
studi
lower
airway
tract
superinfect
affect
patient
patient
respiratori
symptom
incid
drop
patient
cap
consideredvin
word
discard
case
pneumonia
like
relat
nosocomi
factor
addit
measl
pneumon
rel
low
incid
bacteri
pneumonia
especi
compar
studi
mani
patient
report
bacteri
superinfect
may
ascrib
preemptiv
antibiot
therapi
patient
respiratori
symptom
line
hypothesi
patient
document
pulmonari
superinfect
either
expos
prior
antibiot
therapi
n
inappropri
therapi
regard
microbiolog
result
n
fact
prophylact
antibiot
therapi
previous
consid
way
reduc
burden
lung
bacteri
superinfect
primarili
african
children
although
small
trend
favor
antibiot
prophylaxi
recent
metaanalysi
definit
conclus
could
reach
given
poor
qualiti
studi
furthermor
stringent
case
definit
bacteri
pneumonia
includ
mandatori
posit
microbiolog
result
may
well
led
underestim
true
incid
bacteri
pneumonia
anoth
key
find
present
studi
state
lymphopenia
affect
patient
lymphocyt
count
readili
avail
icu
admiss
mechan
measl
abl
induc
lymphocyt
deplet
includ
follow
apoptosi
infect
uninfect
lymphocyt
enhanc
adhes
lymphocyt
secondari
lymphoid
organ
loss
precursor
thymic
epitheli
cell
infect
addit
mv
interfer
lymphocyt
function
suppress
tcell
prolifer
damp
respons
neg
impact
downward
signal
function
alter
innat
immun
also
assum
report
declin
nk
cell
activ
compromis
dendrit
cell
chemotaxi
state
immunosuppress
start
soon
onset
morbil
rash
age
depend
tend
last
longer
adult
turn
expos
patient
greater
risk
superinfect
subsequ
complic
may
part
explain
incid
sever
diseas
age
group
one
key
find
current
studi
poor
outcom
associ
measl
infect
set
host
immunosuppress
immunocompromis
patient
progress
toward
ard
die
high
measl
case
mortal
context
hiv
coinfect
previous
report
african
children
malnutrit
often
addit
concern
pauciti
data
regard
adult
patient
countri
high
standard
health
care
immunocompromis
host
vulner
mv
infect
remain
fulli
elucid
studi
human
patient
primat
point
delay
viru
clearanc
case
concurr
immunosuppress
suggest
immunocompromis
patient
might
expos
viru
deleteri
effect
extend
period
time
accordingli
patient
develop
ard
consequ
measlesinduc
ard
later
stage
diseas
reflect
delay
initi
symptom
icu
admiss
median
iqr
whether
sever
respiratori
impair
subset
patient
result
direct
consequ
viru
per
se
late
bacteri
superinfect
specul
author
remain
determin
addit
immunocompromis
patient
expos
mv
like
develop
specif
histopatholog
pattern
affect
lung
known
hecht
giant
cell
pneumonia
document
case
current
studi
autopsi
find
set
includ
degener
bronchial
bronchiolar
epithelium
interstiti
pneumonia
giant
cell
alveolar
wall
furthermor
advers
effect
mv
patient
immun
statu
might
combin
patient
underli
immunosuppress
thu
increas
risk
superinfect
final
measl
infect
immunocompromis
patient
especi
deceiv
otherwis
uncommon
complic
hallmark
rash
may
limit
absent
word
diagnosi
measlesinduc
ard
consid
immunocompromis
patient
even
absenc
morbil
exanthema
caus
rule
assess
patient
immun
statu
local
measl
epidem
whether
risk
factor
recogn
sever
infect
name
obes
chronic
respiratori
diseas
pregnanc
also
appli
measlesinduc
pneumon
could
assess
accur
current
studi
given
size
nonetheless
note
patient
measl
pneumon
n
prior
histori
chronic
respiratori
impair
figur
close
report
sever
infect
howev
chronic
respiratori
diseas
consist
mainli
intermitt
asthma
n
obes
seem
convey
risk
sever
diseas
affect
patient
pregnanc
repeatedli
report
associ
sever
infect
may
also
hold
true
measl
current
studi
patient
pregnant
enjoy
rel
benign
cours
infect
sever
respiratori
neurolog
complic
despit
requir
admiss
icu
note
set
pregnanc
measl
known
caus
fetal
growth
restrict
prematur
birth
spontan
abort
respect
complic
cours
measl
eventless
patient
underw
cesarean
deliveri
fetal
growth
restrict
week
gestat
sever
acut
respiratori
syndrom
sar
pneumocysti
jirovecii
pneumonia
condit
histopatholog
studi
document
extens
pulmonari
injuri
well
tissu
necrosi
cystic
lesion
case
pneumocysti
jirovecii
infect
factor
said
promot
occurr
air
leak
diseas
likewis
routin
followup
chest
ct
scan
examin
dissemin
cystic
lesion
lung
observ
case
measl
pneumon
complic
ard
see
figur
panel
likewis
necropsi
examin
patient
diagnos
measl
shown
evid
diffus
lung
injuri
includ
necrosi
typei
pneumocyt
although
latter
featur
found
predominantli
immunocompromis
patient
hecht
giant
cell
pneumonia
keep
result
patient
air
leak
diseas
current
studi
immunocompromis
sinc
air
leak
event
occur
patient
use
mechan
ventil
set
ard
rule
barotrauma
either
import
cofactor
primari
culprit
ventilatori
set
record
air
leak
diseas
occur
howev
high
rate
air
leak
diseas
current
studi
well
grow
bodi
evid
urg
physician
use
lungprotect
ventil
emphas
spectrum
airway
infect
relat
measl
vast
includ
upper
airway
tract
current
studi
found
case
tracheobronch
case
otiti
case
sinus
similar
measl
pneumon
upper
airway
infect
aris
either
due
direct
viral
infect
bacteri
superinfect
adult
current
studi
bacteri
coinfect
superinfect
document
patient
although
upper
airway
infect
may
appear
primari
concern
patient
organ
failur
icu
physician
awar
measlesassoci
manifest
may
lead
bacteri
superinfect
measl
enceph
regard
rare
complic
occur
approxim
case
morbid
mortal
rate
high
overal
prognosi
may
wors
adult
young
children
accordingli
seri
patient
display
sever
motor
impair
followup
measl
give
rise
myriad
clinic
manifest
set
pie
seizur
mening
multifoc
neurolog
deficit
includ
sign
myeliti
alter
mental
statu
observ
patient
rank
among
commonli
report
symptom
patient
mild
lymphocyt
pleocytosi
hyperproteinorachia
csf
examin
note
previou
report
key
pathogen
mechan
pie
believ
demyelin
mediat
autoimmun
process
stage
recoveri
infect
gener
within
week
exanthema
current
studi
abl
confirm
result
none
patient
pie
test
presenc
mv
csf
pcr
accordingli
distinct
neuropatholog
featur
includ
perivascular
inflamm
demyelin
resembl
featur
experiment
allerg
enceph
furthermor
experiment
data
support
occurr
cellmedi
hyperact
myelin
base
protein
cours
diseas
line
interpret
clinic
imag
featur
diseas
bear
strong
resembl
acut
dissemin
encephalomyel
adem
case
pie
mri
perform
day
follow
initi
symptom
demonstr
diffus
hypersign
affect
cervic
dorsal
lumbar
medulla
flair
sequenc
find
consist
adem
illustr
figur
brain
imag
investig
neg
remain
patient
howev
case
sole
brain
imag
perform
ct
scan
notori
insensit
techniqu
detect
white
matter
lesion
characterist
adem
patient
mri
imag
undertaken
almost
month
initi
symptom
therefor
transient
lesion
may
miss
howev
mv
elicit
autoimmun
respons
clear
mibe
affect
immunocompromis
host
week
month
onset
measl
far
case
report
kidney
transplant
recipi
brain
biopsi
definit
ascertain
diagnosi
mibe
follow
clinic
laboratori
investig
lend
support
hypothesi
normal
csf
analysi
b
histori
epilepsi
focal
gener
c
seroconvers
cours
neurolog
disord
signific
clinic
improv
withhold
immunosuppress
regimen
time
modul
patient
immunosuppress
critic
trigger
stall
neurolog
diseas
progress
least
set
mibe
consist
previou
report
mibe
complic
aris
case
sever
cellmedi
impair
caus
viru
persist
central
nervou
system
cn
neurolog
symptom
apart
transplant
clinic
set
favor
mibe
occurr
includ
mainli
hiv
infect
chemotherapi
hematolog
malign
immunosuppress
therapi
autoimmun
diseas
mild
laboratori
abnorm
includ
thrombocytopenia
elev
ck
level
aminotransferas
common
find
measl
infect
seldom
give
rise
overt
clinic
complic
reflect
system
natur
measl
infect
thrombocytopenia
develop
earli
stage
infect
presum
consequ
megacaryocyt
infect
viru
bleed
complic
result
thrombocytopenia
known
occur
rare
account
major
hemorrhag
likewis
elev
aminotransferas
level
frequent
affect
patient
could
indic
either
ongo
rhabdomyolysi
less
commonli
measlesassoci
hepat
report
previous
liver
failur
result
measl
except
observ
current
studi
asymptomat
rhabdomyolysi
anoth
frequent
metabol
disturb
although
precis
mechan
remain
elus
occas
rhabdomyolysi
sever
enough
induc
acut
renal
failur
patient
current
studi
final
lymphopenia
highli
preval
exemplifi
studi
affect
patient
lymphocyt
count
readili
avail
admiss
physiopatholog
signific
review
previous
franc
engag
bid
promot
widespread
measl
vaccin
sinc
singl
inject
measl
vaccin
offici
includ
vaccin
schedul
infant
age
month
span
year
immun
measl
rose
time
measl
ceas
endem
diseas
among
children
sharp
declin
associ
morbid
mortal
record
howev
immun
rate
stall
second
inject
ad
schedul
part
noncompulsori
catch
program
design
unvaccin
individu
also
follow
report
highlight
risk
wane
immun
singl
inject
strategi
yet
immun
still
reach
suffici
level
time
measl
outbreak
struck
franc
surprisingli
patient
develop
measl
current
seri
young
adult
first
wellknown
patient
age
group
tend
present
sever
measlesassoci
complic
second
accord
previou
data
patient
vaccin
statu
document
n
either
vaccin
n
receiv
singl
inject
vaccin
n
twentyeight
patient
born
critic
period
time
poor
immun
rate
conclud
measl
epidem
larg
reflect
insuffici
vaccin
coverag
result
converg
evid
stem
european
countri
third
clear
immun
coverag
rate
short
unlik
provid
herd
protect
imped
circul
measl
viru
small
group
unvaccin
subject
given
viru
extrem
contagi
natur
consequ
pocket
suscept
individu
act
reservoir
capabl
fuel
new
outbreak
unprotect
young
adult
greatli
expos
henc
gradual
shift
clinic
pattern
measl
childhood
gener
benign
infect
lethal
diseas
affect
young
adult
effort
reinforc
measl
immun
vaccin
program
fraught
resist
individu
small
commun
oppos
vaccin
variou
reason
includ
scientif
misinform
religi
belief
custom
mispercept
diseas
exagger
concern
regard
safeti
anoth
sourc
concern
impact
global
travel
may
contribut
measl
import
howev
current
studi
lend
support
mechan
sinc
case
measl
indigen
acquir
ribavirin
repres
genuin
antivir
treatment
test
clinic
set
measl
infect
vitro
studi
highlight
abil
interfer
viru
replic
cycl
howev
clinic
studi
relat
adult
patient
measl
pneumon
remain
scarc
variabl
drug
administr
rout
conduct
use
sound
methodolog
measl
epidem
forni
et
al
report
adult
patient
sever
respiratori
compromis
relat
measl
infect
five
patient
exhibit
respiratori
improv
follow
initi
intraven
ribavirin
therapi
immunocompromis
patient
experi
ribavirin
best
anecdot
success
vari
patient
pneumon
mibe
current
case
seri
patient
immunocompromis
sever
measl
pneumon
protract
cours
ribavirin
although
ribavirin
therapi
initi
promptli
onset
diseas
immunocompromis
patient
respiratori
condit
progress
ard
ultim
death
case
treatment
withheld
day
ribavirininduc
hemolysi
patient
affect
mibe
ribavirin
withdrawn
day
initi
result
insuffici
evid
sustain
indic
see
tabl
best
knowledg
current
studi
repres
largest
assess
measlesrel
complic
manag
set
icu
nevertheless
sever
limit
underlin
first
studi
suggest
possibl
risk
factor
sever
measl
first
foremost
immunodepress
howev
small
size
studi
popul
statist
analysi
could
perform
presum
risk
factor
sever
diseas
could
ascertain
consequ
result
await
confirm
either
larger
studi
casecontrol
studi
similar
reason
connect
measl
potenti
specif
complic
extraalveolar
air
leak
diseas
remain
specul
pattern
complic
induc
measl
includ
proport
lethal
adult
case
neurolog
complic
known
differ
area
anoth
access
health
care
resourc
major
determin
thu
known
whether
spectrum
complic
suspect
risk
factor
sever
diseas
describ
current
studi
applic
region
world
despit
effort
devot
gather
mani
case
measl
possibl
case
collect
exhaust
consequ
may
underestim
true
incid
sever
measl
requir
icu
manag
complic
measl
diseas
protean
clinic
manifest
among
respiratori
neurolog
complic
ard
pie
dread
special
attent
warrant
immunocompromis
individu
measl
occur
set
lead
lifethreaten
complic
may
requir
icu
manag
diagnosi
measl
infect
immunocompromis
patient
challeng
face
specif
complic
absent
atyp
morbil
rash
manag
patient
measl
pneumon
use
mechan
ventil
physician
awar
patient
may
predispos
barotrauma
airway
bacteri
superinfect
like
favor
mvinduc
immunosuppress
repres
addit
concern
activ
sought
time
patient
present
sever
respiratori
impair
immunomodulatori
therapi
antivir
treatment
ribavirin
may
play
role
manag
patient
affect
pie
measlesinduc
ard
investig
need
consid
standard
care
primari
prevent
adequ
vaccin
remain
effect
therapeut
mean
communitywid
outbreak
